Thrivent Financial For Lutherans Editas Medicine, Inc. Transaction History
Thrivent Financial For Lutherans
- $28.6 Billion
- Q1 2025
A detailed history of Thrivent Financial For Lutherans transactions in Editas Medicine, Inc. stock. As of the latest transaction made, Thrivent Financial For Lutherans holds 61,111 shares of EDIT stock, worth $94,110. This represents 0.0% of its overall portfolio holdings.
Number of Shares
61,111
Previous 61,111
-0.0%
Holding current value
$94,110
Previous $77,000
7.79%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding EDIT
# of Institutions
230Shares Held
53.1MCall Options Held
412KPut Options Held
355K-
Black Rock Inc. New York, NY7.78MShares$12 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.47MShares$11.5 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny2.75MShares$4.23 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA1.94MShares$2.99 Million0.0% of portfolio
-
State Street Corp Boston, MA1.87MShares$2.88 Million0.0% of portfolio
About Editas Medicine, Inc.
- Ticker EDIT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 68,737,200
- Market Cap $106M
- Description
- Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads t...